• Ms.Amy Lu
    Tel: 027-84306245

  • Mobile:
  • Tel:027-84306245
  • Fax:
  • URL:http://www.wondapharm.com
  • Province/state:Hubei
  • City:Wuhan
  • Street:Wuhan Private Science and Technology Park , Wuhan, China
  • MaxCard:
Home > Products >  Anastrozole// Arimidex For Breast Cancer Treatment with high purity

Anastrozole// Arimidex For Breast Cancer Treatment with high purity CAS NO.120511-73-1

  • Min.Order: 10 Gram
  • Payment Terms: T/T,Western Union,MoneyGram
  • Product Details

Keywords

  • Anastrozole
  • Arimidex
  • Anastrozole powder

Quick Details

  • ProName: Anastrozole// Arimidex For Breast Canc...
  • CasNo: 120511-73-1
  • Molecular Formula: C17H19N5
  • Appearance: white powder
  • Application: a patient with advanced breast cancer ...
  • DeliveryTime: immediately after payment receives
  • PackAge: discreet packing
  • Port: HK, Shanghai, Shenzhen
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: cool and dry place
  • Transportation: email: wonda-chem@outlook.com
  • LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

 

 

Details

Anastrozole / Arimidex For Breast Cancer Treatment CAS : 120511-73-1

 

Product Description

 

Anastrozole (INN) (marketed under the trade name Arimidex by AstraZeneca) is a non-steroidal aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and post-menopausal women. The severity of breast cancer can be increased by estrogen, as sex hormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The patent on Arimidex by AstraZeneca expired June 2010.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic health system.

 

Specification

 

Items

Standard

Results

Description

Off White crystalline powder

Complies

Solubility

Freely soluble in methanol,acetone,ethanol and tetrahydrofuran.And very soluble in acetonitrile

Complies

Total Impurity

max.0.5%

0.18%

Total Unspecified Impurity

max. 0.2%

0.08%

Individual unspecified impurlty

max. 0.1%

0.05%

Related compound B

max. 0.2%

0.07%

Related compound C

max. 0.2%

0.04%

Related compound D

max. 0.1%

0.05%

Related compound E

max. 0.1%

0.06%

Limit of cyclohexane

max. 0.08%

ND

Limit of ethylacetate

max. 0.1%

0.07%

Melting point

81.0~84.0°C

82.5~83.2°C

Water

max. 0.3%

0.21%

Residue on ignition

max. 0.1%

0.07%

Heavy Metals

max.0.001%

Complies

Assay(HPLC)

98.0%~102.0%

99.8%

Storage

Cool and dry

Conclusion

It complies to USP32 .

 

Function and Application

 

Third generation aromatase inhibitors. A patient with advanced breast cancer after menopause.

 

 

 

 

 

Packing and shipping

 

 

Other products of this supplier

lookchemhot product CAS New CAS